Skip to content
GLP-1 Scorecard
Menu
Graded #161

VyrarX

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Visit VyrarXWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$179/mo (starting dose, compounded)
Tirzepatide
$329/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh VyrarX against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because VyrarX dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value61/100
Dose & formulation64/100
Clinical oversight84/100
Labs & monitoring72/100
Fulfillment71/100
Contract terms55/100

Strengths

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Where it loses points

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

Bottom line — Grade C

Best for: Shoppers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.

Ranked #161 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest VyrarX — the realistic shortlist.

Somi Health#158

Somi Health is a telehealth weight-loss provider offering compounded GLP-1 medications - compounded semaglutide and tirzepatide injections plus an oral semaglutide tablet.

GOAL.MD#159

GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound.

Trava Health#160

Houston-based DTC telehealth offering compounded semaglutide+B12 and tirzepatide+B12 through SIX named 503A compounding pharmacy partners disclosed on Trava's own Terms + Telehealth Consent pages (Postmeds/TruePill, EHT/Curexa, Apostrophe, XeCare, Wells American/Promed, Optimal Balance/OBP).

Noom Med#162

Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication program available.

PauseRX#163

PauseRX is a nationwide compounded GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and publishes a full FDA compounded-medication disclaimer.

System Labs#104

One product at one flat price — compounded tirzepatide at $179/mo month-to-month, the same figure at every dose, with no prepay ladder to buy down to and no membership fee — behind a named three-physician medical board and an unnamed pharmacy.

The 22 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect VyrarX's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on VyrarX's site. Not medical advice; see our disclosure.

← Back to the scorecard